Citadel Advisors’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $257K | Buy |
+15,300
| New | +$274K | ﹤0.01% | 10839 |
|
|
2025
Q4 | – | Sell |
-15,200
| Closed | -$188K | – | 12791 |
|
|
2025
Q3 | $188K | Sell |
15,200
-700
| -4% | -$8.21K | ﹤0.01% | 11320 |
|
|
2025
Q2 | $183K | Buy |
15,900
+6,000
| +61% | +$71.2K | ﹤0.01% | 10757 |
|
|
2025
Q1 | $148K | Sell |
9,900
-5,500
| -36% | -$92.1K | ﹤0.01% | 10891 |
|
|
2024
Q4 | $267K | Sell |
15,400
-7,800
| -34% | -$151K | ﹤0.01% | 9898 |
|
|
2024
Q3 | $430K | Buy |
23,200
+12,600
| +119% | +$253K | ﹤0.01% | 8585 |
|
|
2024
Q2 | $215K | Sell |
10,600
-111,000
| -91% | -$1.96M | ﹤0.01% | 9773 |
|
|
2024
Q1 | $2.08M | Sell |
121,600
-5,600
| -4% | -$88.1K | ﹤0.01% | 5445 |
|
|
2023
Q4 | $2.25M | Buy |
127,200
+105,000
| +473% | +$2.12M | ﹤0.01% | 5157 |
|
|
2023
Q3 | $533K | Buy |
22,200
+3,100
| +16% | +$76.1K | ﹤0.01% | 7925 |
|
|
2023
Q2 | $444K | Sell |
19,100
-8,100
| -30% | -$183K | ﹤0.01% | 8201 |
|
|
2023
Q1 | $600K | Buy |
27,200
+4,500
| +20% | +$105K | ﹤0.01% | 7943 |
|
|
2022
Q4 | $460K | Sell |
22,700
-3,500
| -13% | -$67.8K | ﹤0.01% | 8417 |
|
|
2022
Q3 | $353K | Sell |
26,200
-11,000
| -30% | -$185K | ﹤0.01% | 9211 |
|
|
2022
Q2 | $737K | Buy |
37,200
+16,000
| +75% | +$425K | ﹤0.01% | 7735 |
|
|
2022
Q1 | $671K | Sell |
21,200
-12,500
| -37% | -$350K | ﹤0.01% | 8669 |
|
|
2021
Q4 | $752K | Sell |
33,700
-1,500
| -4% | -$39.1K | ﹤0.01% | 8645 |
|
|
2021
Q3 | $977K | Sell |
35,200
-26,100
| -43% | -$795K | ﹤0.01% | 8214 |
|
|
2021
Q2 | $2.39M | Sell |
61,300
-24,600
| -29% | -$882K | ﹤0.01% | 6161 |
|
|
2021
Q1 | $2.47M | Buy |
85,900
+69,000
| +408% | +$2.36M | ﹤0.01% | 5903 |
|
|
2020
Q4 | $448K | Sell |
16,900
-15,100
| -47% | -$308K | ﹤0.01% | 8349 |
|
|
2020
Q3 | $488K | Sell |
32,000
-5,600
| -15% | -$117K | ﹤0.01% | 7345 |
|
|
2020
Q2 | $764K | Sell |
37,600
-1,800
| -5% | -$32.3K | ﹤0.01% | 6327 |
|
|
2020
Q1 | $407K | Buy |
39,400
+7,700
| +24% | +$215K | ﹤0.01% | 6798 |
|
|
2019
Q4 | $1.19M | Buy |
31,700
+11,300
| +55% | +$508K | ﹤0.01% | 5277 |
|
|
2019
Q3 | $951K | Sell |
20,400
-10,600
| -34% | -$493K | ﹤0.01% | 5683 |
|
|
2019
Q2 | $1.62M | Sell |
31,000
-20,900
| -40% | -$1.23M | ﹤0.01% | 4883 |
|
|
2019
Q1 | $3.58M | Buy |
51,900
+19,800
| +62% | +$1.33M | ﹤0.01% | 3479 |
|
|
2018
Q4 | $1.92M | Sell |
32,100
-5,400
| -14% | -$466K | ﹤0.01% | 4216 |
|
|
2018
Q3 | $4.34M | Buy |
37,500
+26,600
| +244% | +$3M | ﹤0.01% | 3175 |
|
|
2018
Q2 | $1.38M | Sell |
10,900
-2,800
| -20% | -$341K | ﹤0.01% | 4679 |
|
|
2018
Q1 | $1.48M | Sell |
13,700
-31,600
| -70% | -$3.5M | ﹤0.01% | 4192 |
|
|
2017
Q4 | $4.96M | Buy |
45,300
+18,200
| +67% | +$1.82M | ﹤0.01% | 2488 |
|
|
2017
Q3 | $2.67M | Sell |
27,100
-3,600
| -12% | -$349K | ﹤0.01% | 3062 |
|
|
2017
Q2 | $3.11M | Buy |
30,700
+13,100
| +74% | +$1.41M | ﹤0.01% | 2618 |
|
|
2017
Q1 | $2.03M | Sell |
17,600
-13,100
| -43% | -$1.52M | ﹤0.01% | 3057 |
|
|
2016
Q4 | $3.69M | Buy |
30,700
+8,800
| +40% | +$974K | ﹤0.01% | 2299 |
|
|
2016
Q3 | $2.46M | Sell |
21,900
-15,800
| -42% | -$1.82M | ﹤0.01% | 2733 |
|
|
2016
Q2 | $4.67M | Sell |
37,700
-8,800
| -19% | -$1.06M | 0.01% | 1877 |
|
|
2016
Q1 | $5.23M | Buy |
46,500
+24,300
| +109% | +$2.52M | 0.01% | 1726 |
|
|
2015
Q4 | $2.41M | Sell |
22,200
-17,800
| -45% | -$2.04M | ﹤0.01% | 2554 |
|
|
2015
Q3 | $3.99M | Sell |
40,000
-800
| -2% | -$87K | ﹤0.01% | 2173 |
|
|
2015
Q2 | $4.65M | Buy |
40,800
+8,300
| +26% | +$1.01M | ﹤0.01% | 2135 |
|
|
2015
Q1 | $3.4M | Buy |
32,500
+12,500
| +63% | +$1.33M | ﹤0.01% | 2446 |
|
|
2014
Q4 | $2.41M | Sell |
20,000
-9,100
| -31% | -$1.2M | ﹤0.01% | 2694 |
|
|
2014
Q3 | $4.26M | Buy |
29,100
+16,700
| +135% | +$2.58M | ﹤0.01% | 2129 |
|
|
2014
Q2 | $2.07M | Sell |
12,400
-10,100
| -45% | -$1.8M | ﹤0.01% | 2708 |
|
|
2014
Q1 | $4.46M | Buy |
22,500
+2,200
| +11% | +$415K | 0.01% | 1885 |
|
|
2013
Q4 | $3.88M | Buy |
20,300
+9,200
| +83% | +$1.71M | 0.01% | 1892 |
|
|
2013
Q3 | $1.88M | Sell |
11,100
-2,100
| -16% | -$326K | ﹤0.01% | 2466 |
|
|
2013
Q2 | $2M | Buy |
+13,200
| New | +$1.87M | ﹤0.01% | 2493 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Citadel Advisors's CLB Position: Q1 2026 in Review
Citadel Advisors increased its Core Laboratories (CLB) stake by 319% in Q1 2026, buying an estimated $2.11M and bringing the position to 154,800 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #5541.
Citadel Advisors first reported a position in CLB in Q2 2013 and has held it in 46 quarters since. The position peaked at $44.3M in Q1 2019. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Citadel Advisors held 154,800 shares of Core Laboratories worth $2.6M as of Q1 2026.
- Citadel Advisors bought 117,867 Core Laboratories shares in Q1 2026, an estimated $2.11M.
- Core Laboratories made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5541 holding.
- Citadel Advisors first reported a position in Core Laboratories in Q2 2013 and has held it in 46 quarters since.
- Citadel Advisors's Core Laboratories position peaked at $44.3M in Q1 2019.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.